Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2020
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)P A Fasching, T Link, J Hauke, et al.
Cancer Immunology, Immunotherapy : CII|October 8, 2016
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinomaAjjai Alva, Gregory A Daniels, Michael K K Wong, et al.
ESMO Open|May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancerG Galffy, I Lugowska, E V Poddubskaya, et al.
Cancer Research Communications|August 22, 2024
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed TherapyElisabeth Heath, Gregory Dyson, Jennifer R Ribeiro, et al.
European Urology|December 18, 2017
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on OutcomesMatthew D Galsky, Huan Wang, Noah M Hahn, et al.
Clinical Genitourinary Cancer|July 29, 2020
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 StudyNicholas J Vogelzang, Mark R Olsen, Joshua J McFarlane, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Excitation/inhibition imbalance and conversion to psychosis in the clinical high risk syndrome: Biophysical modeling finds reduced pyramidal cell excitability across EEG paradigmsJulia Rodriguez-Sanchez, Daniel J Hauke, Dimitris Pinotsis, et al.
Translational Psychiatry|May 25, 2021
Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosisDaniel J Hauke, André Schmidt, Erich Studerus, et al.
Biological Psychiatry|April 23, 2026
Biophysical modeling of excitation/inhibition balance and conversion to psychosis in the clinical high risk syndromeJulia Rodriguez-Sanchez, Daniel J Hauke, Dimitris Pinotsis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2021
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate CancerSamuel R Denmeade, Hao Wang, Neeraj Agarwal, et al.
Pageof 9